Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
Objective To compare the efficacy and prognosis of imatinib and sirolimus as second-line treatment for steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Clinical data of 33 patients diagnosed as SR-cGVHD afte...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Editorial Office of Journal of Third Military Medical University
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/413c7351afd84e67a2f6d92b036de682 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|